Javascript must be enabled to continue!
PS02.022: INDOCYANINE GREEN: A USEFUL TOOL IN MINIMALLY INVASIVE ESOPHAGEAL CANCER SURGERY
View through CrossRef
Abstract
Background
Minimally invasive approach to esophageal cancer has been accepted as the standard of care in many centers. Nontheless, some technical difficulties are encountered during surgery. A proper vascularization of the gastric tube is mandatory to avoid the dreadful complication of a leak or of gastric conduit necrosis. On the other hand, there is controversy on the identification of sentinel lymph node in early esophageal cancer and on the extent of lymphadenectomy in locally advanced tumours. Indocyanine green (ICG) is a sterile, anionic, water-soluble but relatively hydrophobic, tricarbocyanine molecule, which is bound to plasma proteins when intravenously injected. It is extracted by the liver appearing in the bile around 8 minutes after injection. When injected outside the blood vessels, ICG reaches the nearest lymph node within 15 minutes and after 1 to 2 hours it binds to the regional lymph nodes. The usual dose of ICG is 0.1 - 0.5mg/mL/kg. ICG becomes fluorescent once excited with near-infrared (NIR) light at about 820 nm. The fluorescence released by ICG may be detected using specially developed cameras.
Methods
A systematic review of the literature of ICG in esophageal surgery was carried on February 2018 using the following terms: esophagus, indocyanine green, ICG, surgery, angiography, lymph node, and combinations of the above.
Results
The technique of ICG angiography for vascular assessment of the gastroepiploic arcade and gastric conduit is explained and the published results are review. The use of ICG for the evaluation of sentinel lymph node in early esophageal cancer and of lymph node mapping for regional lymph nodes is explained and current evidence is reviewed.
Conclusion
ICG use in esophageal surgery is still a novel and promising technique. It could help to reduce anastomotic leak by means of vascular assessment of the gastric conduit, locate lymph nodes out of the usual fields of lymphadenectomy and locate the sentinel lymph node in early esophageal cancer
Disclosure
All authors have declared no conflicts of interest.
Title: PS02.022: INDOCYANINE GREEN: A USEFUL TOOL IN MINIMALLY INVASIVE ESOPHAGEAL CANCER SURGERY
Description:
Abstract
Background
Minimally invasive approach to esophageal cancer has been accepted as the standard of care in many centers.
Nontheless, some technical difficulties are encountered during surgery.
A proper vascularization of the gastric tube is mandatory to avoid the dreadful complication of a leak or of gastric conduit necrosis.
On the other hand, there is controversy on the identification of sentinel lymph node in early esophageal cancer and on the extent of lymphadenectomy in locally advanced tumours.
Indocyanine green (ICG) is a sterile, anionic, water-soluble but relatively hydrophobic, tricarbocyanine molecule, which is bound to plasma proteins when intravenously injected.
It is extracted by the liver appearing in the bile around 8 minutes after injection.
When injected outside the blood vessels, ICG reaches the nearest lymph node within 15 minutes and after 1 to 2 hours it binds to the regional lymph nodes.
The usual dose of ICG is 0.
1 - 0.
5mg/mL/kg.
ICG becomes fluorescent once excited with near-infrared (NIR) light at about 820 nm.
The fluorescence released by ICG may be detected using specially developed cameras.
Methods
A systematic review of the literature of ICG in esophageal surgery was carried on February 2018 using the following terms: esophagus, indocyanine green, ICG, surgery, angiography, lymph node, and combinations of the above.
Results
The technique of ICG angiography for vascular assessment of the gastroepiploic arcade and gastric conduit is explained and the published results are review.
The use of ICG for the evaluation of sentinel lymph node in early esophageal cancer and of lymph node mapping for regional lymph nodes is explained and current evidence is reviewed.
Conclusion
ICG use in esophageal surgery is still a novel and promising technique.
It could help to reduce anastomotic leak by means of vascular assessment of the gastric conduit, locate lymph nodes out of the usual fields of lymphadenectomy and locate the sentinel lymph node in early esophageal cancer
Disclosure
All authors have declared no conflicts of interest.
Related Results
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract
Introduction
Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
063. ROBOTIC ASSISTED MIMINALLY INVASIVE IVOR-LEWIS ESOPHAGECTOMY VERSUS CONVENTIONAL MINIMALLY INVASIVE IVOR-LEWIS ESOPHAGECTOMY
063. ROBOTIC ASSISTED MIMINALLY INVASIVE IVOR-LEWIS ESOPHAGECTOMY VERSUS CONVENTIONAL MINIMALLY INVASIVE IVOR-LEWIS ESOPHAGECTOMY
Abstract
Background
Minimally invasive technique for esophagectomy has emerged as the standard of care for resectable esophageal...
The analysis on Tiam2 for expression in esophageal carcinoma: A descriptive study
The analysis on Tiam2 for expression in esophageal carcinoma: A descriptive study
Rationale:
To investigate T lymphoma invasion and metastasis inducing factor 2 (Tiam2) protein for expression in esophageal carcinoma and relationship with clinical fea...
CircBCAR3 accelerates esophageal cancer tumorigenesis and metastasis via sponging miR-27a-3p
CircBCAR3 accelerates esophageal cancer tumorigenesis and metastasis via sponging miR-27a-3p
Abstract
Rationale
Circular RNAs (circRNAs) have been demonstrated to contribute to esophageal cancer progression. CircBCAR3 (hsa_circ_0007624) is p...
Molecular Marker Discovery and effect Evaluation of KRT17 and COL1A1 in Esophageal Cancer Detection
Molecular Marker Discovery and effect Evaluation of KRT17 and COL1A1 in Esophageal Cancer Detection
Abstract
Esophageal cancer is one of the malignant tumors in the digestive system. Because the early symptoms of esophageal cancer are occult and lack effective screening o...
022. TREATMENT EXPERIENCE OF ESOPHAGEAL FISTULA INDUCED BY NEOADJUVANT THERAPY IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A SINGLE-CENTER EXPERIENCE
022. TREATMENT EXPERIENCE OF ESOPHAGEAL FISTULA INDUCED BY NEOADJUVANT THERAPY IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A SINGLE-CENTER EXPERIENCE
Abstract
Background
Esophageal squamous cell carcinoma (ESCC) is typically treated with neoadjuvant therapy followed by esophage...
ÖZOFAGUS ATREZİLİ YENİDOĞANLARDA ANESTEZİK RİSKLER, MORBİDİTE VE MORTALİTE
ÖZOFAGUS ATREZİLİ YENİDOĞANLARDA ANESTEZİK RİSKLER, MORBİDİTE VE MORTALİTE
Giriş:
Özofagus atrezisi (ÖA), özofagusun proksimal ve distal bölümlerinin bağlantısının olmamasıdır ve 3000-4500 canlı
doğumda bir görülür. Özofagus atrezisi ve trakeoözofageal f...
Risk Factors for Esophageal Cancer in the Cohort of Nuclear Facility Workers
Risk Factors for Esophageal Cancer in the Cohort of Nuclear Facility Workers
Purpose: To assess the influence of non-radiation factors and occupational radiation exposure on the incidence risk of esophageal cancer in nuclear workers considering various hist...

